Literature DB >> 17912010

Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma.

Marco Del Chiaro1, Alessandro Zerbi, Massimo Falconi, Laura Bertacca, Marco Polese, Nora Sartori, Ugo Boggi, Giorgio Casari, Bianca Maria Longoni, Roberto Salvia, Maria Adelaide Caligo, Valerio Di Carlo, Paolo Pederzoli, Silvano Presciuttini, Franco Mosca.   

Abstract

BACKGROUND/AIMS: Pancreatic cancer is a leading cause of cancer-related death; the most consistently identified risk factors are smoking and family history. Our aims were to examine familial aggregations of pancreas and other cancers, and to determine the relative risk of the family members.
METHODS: We prospectively collected data on the families of patients presenting with pancreatic ductal adenocarcinoma. Smoking habits and alcohol consumption of the probands were compared with the available statistics on the Italian population. Mortality from cancer was investigated in first-degree relatives, and age-dependent risks of dying from pancreatic cancer and other tumors were compared with background population levels.
RESULTS: Data for 570 families were collected, including 9,204 relatives. Probands were 3- to 5-fold more often heavy smokers than the general population, and 9.3% of them reported a positive family history of pancreatic cancer. In first-degree relatives, only mortality from pancreatic cancer was significantly increased (relative risk at age 85 years = 2.7). Lifetime risk of dying of pancreas cancer was 4.1% for the relatives of all probands, and was 7.2% for the relatives of probands who developed disease before 60 years of age.
CONCLUSIONS: The data suggest that genetic susceptibility to pancreatic cancer may be attributable, in addition to BRCA2, to moderate- to low-penetrance gene(s). (c) 2007 S. Karger AG, Basel and IAP.

Entities:  

Mesh:

Year:  2007        PMID: 17912010     DOI: 10.1159/000108963

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  14 in total

Review 1.  Familial pancreatic cancer--current knowledge.

Authors:  Detlef K Bartsch; Thomas M Gress; Peter Langer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-05       Impact factor: 46.802

2.  On pancreatic cancer screening by magnetic resonance imaging with the recent evidence by Del Chiaro and colleagues.

Authors:  Yì-Xiáng J Wáng; Jing-Shan Gong; Romaric Loffroy
Journal:  Chin J Cancer Res       Date:  2015-08       Impact factor: 5.087

Review 3.  Familial pancreatic cancer--status quo.

Authors:  Volker Fendrich; Peter Langer; Detlef K Bartsch
Journal:  Int J Colorectal Dis       Date:  2013-08-16       Impact factor: 2.571

Review 4.  Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis.

Authors:  Jennifer Permuth-Wey; Kathleen M Egan
Journal:  Fam Cancer       Date:  2008-09-02       Impact factor: 2.375

5.  Is intraductal tubulopapillary neoplasia a new entity in the spectrum of familial pancreatic cancer syndrome?

Authors:  Marco Del Chiaro; Raffaella Pozzi Mucelli; John Blomberg; Ralf Segersvärd; Caroline Verbeke
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

6.  Pancreatic adenocarcinoma in young adults in a moroccan population.

Authors:  S Raissouni; G Rais; H Mrabti; F Raissouni; H Mouzount; M Aitelhaj; S El Khoyaali; A Mohtaram; H Errihani
Journal:  J Gastrointest Cancer       Date:  2012-12

7.  Genome-wide association study of pancreatic cancer in Japanese population.

Authors:  Siew-Kee Low; Aya Kuchiba; Hitoshi Zembutsu; Akira Saito; Atsushi Takahashi; Michiaki Kubo; Yataro Daigo; Naoyuki Kamatani; Suenori Chiku; Hirohiko Totsuka; Sumiko Ohnami; Hiroshi Hirose; Kazuaki Shimada; Takuji Okusaka; Teruhiko Yoshida; Yusuke Nakamura; Hiromi Sakamoto
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

8.  Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro.

Authors:  Su-Gang Shen; Dong Zhang; Heng-Tong Hu; Jun-Hui Li; Zheng Wang; Qing-Yong Ma
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

9.  Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

Authors:  Eric J Jacobs; Stephen J Chanock; Charles S Fuchs; Andrea Lacroix; Robert R McWilliams; Emily Steplowski; Rachael Z Stolzenberg-Solomon; Alan A Arslan; H Bas Bueno-de-Mesquita; Myron Gross; Kathy Helzlsouer; Gloria Petersen; Wei Zheng; Ilir Agalliu; Naomi E Allen; Laufey Amundadottir; Marie-Christine Boutron-Ruault; Julie E Buring; Federico Canzian; Sandra Clipp; Miren Dorronsoro; J Michael Gaziano; Edward L Giovannucci; Susan E Hankinson; Patricia Hartge; Robert N Hoover; David J Hunter; Kevin B Jacobs; Mazda Jenab; Peter Kraft; Charles Kooperberg; Shannon M Lynch; Malin Sund; Julie B Mendelsohn; Tracy Mouw; Christina C Newton; Kim Overvad; Domenico Palli; Petra H M Peeters; Aleksandar Rajkovic; Xiao-Ou Shu; Gilles Thomas; Geoffrey S Tobias; Dimitrios Trichopoulos; Jarmo Virtamo; Jean Wactawski-Wende; Brian M Wolpin; Kai Yu; Anne Zeleniuch-Jacquotte
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

10.  Family history of cancer and tobacco exposure in index cases of pancreatic ductal adenocarcinoma.

Authors:  R Lochan; A K Daly; H L Reeves; R M Charnley
Journal:  J Oncol       Date:  2011-04-06       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.